Clinical Pharmacology of Adrenergic Drugs

References

• O'Donnell S R, Wanstall J C. Potency and selectivity in vitro of compounds related to isoprenaline and orciprenaline on beta adrenoreceptors in the guinea pig. Br J Pharmacol 1974; 52: 407
   PubMed Web of Science ®Google Scholar
• O'Donnell S R. A selective beta-adrenoreceptor stimulant (TH 1165a) related to orciprenaline. Eur J Pharmacol 1970; 12: 35
   PubMed Web of Science ®Google Scholar
• O'Donnell S R. Ein selektives Beta-adrenergikum, Th 1165a. lnt J Clin Pharmacol Suppl. 1971; 4: 16
   Google Scholar
• Tabachnick I IA. A summary of the pharmacology and toxicology of albuterol (Proventil). Ann Allergy 1981; 47: 379
   PubMedGoogle Scholar
• Wolfe B B, Harden T K, Molinoff P B. In vitro study of beta-adrenergic receptors. Ann Rev Pharmacol Toxicol 1977; 17: 575
   PubMed Web of Science ®Google Scholar
• Mickey J, Tate R, Lefkowitz R J. Sub-sensitivity of adenylate cyclase and decreased beta adrenergic receptor binding after chronic exposure to (—) isoproterenol in vitro. J Biol Chem 1975; 250: 5727
   PubMed Web of Science ®Google Scholar
• Cannon R E, Slavin R G, Gonarum L M. The effect of asthma of a new beta-blocker, pindolol. Am Heart J 1982; 104: 438
   PubMed Web of Science ®Google Scholar
• MacDonald A, Ingram C C, McNeil R S. The effect of propranolol on airway resistance. Br J Anaesth 1967; 39: 919
   PubMed Web of Science ®Google Scholar
• Gaynard P, Orehek J, Charpin J. Effects de différents produits bronchodilatateurs sur la conductance des vois aériennes dans l'asthme lors d'um blockage beta-adrenergique provoqué. Bull Physio-Path Resp 1972; 8: 625
   PubMedGoogle Scholar
• Szentivanyi A. The beta adrenergic theory of the atopic abnormality in asthma. J Allergy 1968; 42: 203
   Google Scholar
• Popa V. Beta blockade of the bronchial smooth muscle in asthmatic subjects: Audi et alteram partem. J Allergy Clin Immunol 1976; 58: 351
   PubMed Web of Science ®Google Scholar
• Popa V. How to inhale a whiff of bronchodilator?. Chest 1979; 76: 496
   PubMed Web of Science ®Google Scholar
• Newman S P, Pavia D, Maren F, Sheahan N, Clarke S W. Deposition of pressurized aerosols in the human respiratory tract. Thorax 1981; 36: 52
   PubMed Web of Science ®Google Scholar
• Davies D S. Pharmacokinetics of inhaled substances. Postgrad Med J Suppl. 1975; 7: 69
   Google Scholar
• Walker S R, Evans M E, Richards A J, Paterson J W. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 1972; 13: 861
   PubMed Web of Science ®Google Scholar
• Popa V. Quantitative inhalation tests with histamine: Physiologic and pharmacologic correlations, (unpublished)
   Google Scholar
• Ruffin R E, Kenworthy M C, Newhouse M T. Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther 1978; 23: 338
   PubMed Web of Science ®Google Scholar
• Moren F. Drug deposition of pressurized inhalation aerosols. I. Influence of activator tube design. lnt J Pharmacol 1972; 1: 205
   Google Scholar
• Lindgren S B, Formgren H, Moren F. Improved aerosol therapy of asthma: Effect of actuator tube size on drug availability. Eur J Res Dis 1980; 61: 56
   Google Scholar
• Hodges J GC, Milner A D, Stokes G M. Assessment of a new device for delivering aerosol drugs to asthmatic children. Arch Dis Child 1981; 56: 787
   PubMed Web of Science ®Google Scholar
• Hiller C, Mazumcler M, Wilson D, Bone R. Aerodynamic size distribution of metered-dose bronchodilator aerosols. Am Rev Resp Dis 1978; 118: 311
   PubMed Web of Science ®Google Scholar
• Lourenco R. Therapeutic aerosols. Pulmonary Diseases and Disorders, A P Fishman. McGraw-Hill Book Company, New York 1980
   Google Scholar
• Dautrebande L. Microaerosols; Physiology, Pharmacology, Therapeutics. Academic Press, New York 1972; 88
   Google Scholar
• Bouhuys A. Isooprenaline-inhalatie bij asthma bronchialis. Ned T Geneesk 1963; 107: 1739
   PubMedGoogle Scholar
• Zimmerman I, deAlameida A AB, Ulmer W T. Wirkort von beta2-Rezeptoren stimulierende Bronchodilatatoren. Klin Wochr 1980; 58: 395
   PubMedGoogle Scholar
• Nassari W, Zimmerman I, Bouzrina S, Ulmer W T. The site of action of beta2-sympathomimetic bronchodilators in patients with chronic obstructive airway disease. Respiration 1981; 4: 232
   Google Scholar
• Rodenstein D, Stanescu D. Mouth spraying versus inhalation of fenoterol in healthy subjects and asthmatic patients. Br J Dis Chest 1982; 76: 365
   PubMedGoogle Scholar
• Walters E H, Cockroft A, Griffiths T, Rochiocioli K, Davies B H. Optimal dose of salbutamol respiratory solution: Comparison of 3 doses with plasma level. Thorax 1981; 36: 625
   PubMed Web of Science ®Google Scholar
• van der Berg W, Fokkens J, Leferink J G, Kreukniet J, Maes R AA, Bruynzell P LB. Tremor measurement in asthma. Changes after terbutaline administration suggesting beta blockade. Eur J Resp Dis 1982; 63: 392
   PubMedGoogle Scholar
• Morgan C O, Sandier M, Davies D S, Conolly M, Paterson J W, Dollery C T. The metabolic fate of DL[7-3H] isoprenaline in man and dog. Biochem J 1969; 114: 8P
   Web of Science ®Google Scholar
• Leterink J G, van den Berg W, Wagemaker-Engels I, Kreukniet J, Maes R AA. Pharmacokinetics of terbutaline, a β2 sympatomimetic, in healthy volunteers and asthmatics. Arzn Forsch 1982; 32: 159
   PubMed Web of Science ®Google Scholar
• Evans M E, Richards A J, Walker S R, Paterson J W. The fate of 3H salbutainol in man. Biochem J 1971; 125: 27P
   PubMedGoogle Scholar
• Martin L E, Rees J, Tanner R JN. Quantitative determinations of salbutainol in plasma. Biomed Mass Spectrosc 1976; 3: 184
   PubMedGoogle Scholar
• Rominger K L, Pollman W. Comparative pharmacokinetic studies on fenoterol hydrobromide in rat, dog, and man. Ann Forsch 1972; 22: 1196
   PubMedGoogle Scholar
• Conolly M E, Davies D S, Dollery C T, Morgan C D, Paterson J W, Sandier M. Metabolism of isoprenaline in dog and man. Br J Pharmacol 1972; 46: 458
   PubMed Web of Science ®Google Scholar
• Blackwell E W, Briant R H, Conolly M E, Davies D S, Dollery C T. Metabolism of isoprenaline after aerosol and direct intrabronchial administration in man and dog. Br J Pharmacol 1976; 50: 587
   Web of Science ®Google Scholar
• Evans M E, Walker S R, Brittain R T, Paterson J W. The metabolism of salbutamol in man. Xenobiotica 1973; 3: 113
   PubMed Web of Science ®Google Scholar
• van Rossum J M. Pharmacokinetics of inhaled medication. Int J Clin Pharmacol Suppl 1971; 4: 28
   Google Scholar
• Griffin J P, Williams J RE, Maughan E. Studies in the human pharmacology and metabolism of rimiterol (Pulmadil); comparison with isoprenaline. Clin Trials J 1973; 10: 13
   Google Scholar
• Laros C D, von Urk P, Rominger R L. Absorption, distribution, and excretion of the tritium labelled beta stimulator Fenoterol hydrobromide following aerosol administration and ventilation into the bronchial tree. Respiration 1970; 34: 131
   Google Scholar
• Hornblad Y, Ripe E, Magnusson Tegnerk P O. The metabolism and clinical activity of terbutaline and its prodrug Ibuterol. Eur J Clin Pharmacol 1976; 10: 9
   Web of Science ®Google Scholar
• Nilsson H T, Persson K, Tegner K. The metabolism of terbutaline in man. Xenobiotica 1972; 2: 363
   PubMed Web of Science ®Google Scholar
• Lin C, Magat J, Calesnik B, Symchowicz S. Absorption, excretion and urinary metabolic pattern of 3H-albuterol aerosol in man. Xenobiotica 1972; 2: 507
   PubMed Web of Science ®Google Scholar
• Evans M E, Shenfield G M, Thomas N, Walker S R, Paterson J W. The pharmacokinetics of rimiterol in man. Xenobiotica 1974; 4: 69
   PubMed Web of Science ®Google Scholar
• Evans M E, Paterson J W, Sherfield G N, Thomas M, Walker S R. The pharmacokinetics of rimiterol in asthmatic subjects. Br J Pharmacol 1973; 49: 153P
   Web of Science ®Google Scholar
• Williams F M, Briant R H, Dollery C T, Davies D S. The influence of the route of administration on the urinary metabolites of isoetharine. Xenobiotica 1974; 4: 265
   PubMed Web of Science ®Google Scholar
• Buchelt L, Rominger R L. The pharmacokinetics and metabolism of Berotec (fenoterol) in man. Med Proc 1972; 18: 15
   Google Scholar
• Martin L E, Hobson J C, Page J A, Harrison C. Metabolic studies of salbutamol 3H: A new bronchodilator in rat, rabbit, dog and man. Eur J Pharmacol 1971; 14: 183
   PubMed Web of Science ®Google Scholar
• Volicer L, Snider G, Sherter C, Stjarne L, Mathe A A. Epinephrine deposition in control and asthmatic subjects. Int Arch Allergy Appl Immunol 1980; 63: 14
   PubMedGoogle Scholar
• Iravani I, Schmidt U. Wirkung einiger bronchodilatierenden Substanzen auf die Flimmeraktivitat unter besonderer Berucksichtung von Berotec. Int J Clin Pharmacol Suppl 1971; 4: 21
   Google Scholar
• Sackner M A, Epstein S, Wanner A. Effects of beta adrenergic agonists aerosolized by freon propellant on tracheal mucous velocity and cardiac output. Chest 1976; 69: 593
   PubMed Web of Science ®Google Scholar
• Basran G S, Paul W, Morely J, Turner-Warwick M. Evidence in man or synergistic interaction between putative mediators of acute inflammation and asthma. Lancet 1982; 1: 935
   PubMed Web of Science ®Google Scholar
• Gronneberg R, Strandberg K, Stahlenheim G, Zetterstrom O. Effect in man of antiallergic drugs on the immediate and late phase cutaneous allergic reactions induced by anti-lgE. Allergy 1981; 36: 201
   PubMed Web of Science ®Google Scholar
• Franklin W, Michelson A L, Lowell F C, Schiller I W. Bronchodilators and cortico steroids in the treatment of obstructive pulmonary emphysema. N Engl J Med 1958; 258: 774
   PubMed Web of Science ®Google Scholar
• Salome C M, Schoeffel R E, Woolcock A J. Effect of aerosol and oral fenoterol on histamine and metacholine challenge in asthmatic subjects. Thorax 1981; 36: 580
   PubMed Web of Science ®Google Scholar
• Booij-Noora H, Quanjer P H, de Vries K. Protective effect of Berotec in provocation tests using inhalation of specific allergens and histamine. Int J Clin Pharmacol (Suppl) 1971; 4: 69
   Google Scholar
• Jones R S, Wharton M J, Buston M H. The place of physical exercise and bronchodilator drugs in the assessment of the asthmatic child. Arch Dis Child 1963; 38: 539
   PubMed Web of Science ®Google Scholar
• Anderson S D, Searle J P, Rozea P, Bandler L, Theobald G, Lindsay D A. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Resp Dis 1976; 114: 493
   PubMed Web of Science ®Google Scholar
• O'Byrne D M, Morris M, Roberts R, Hargreave F E. Inhibition of the bronchial response to respiratory heat exchange by increasing doses of terbutaline. Thorax 1982; 37: 913
   PubMed Web of Science ®Google Scholar
• Spector S. Effect of selective beta-adrenergic agonist and theophilline on skin tests reactivity and cardiovascular parameters. J Allergy Clin Immunol 1979; 64: 23
   PubMed Web of Science ®Google Scholar
• Chipps B E, Sobotka A K, Sanders J P, Teets K C, Norman P S, Lichtenstein L M. Effect of theophylline and terbutaline on immediate skin tests. J Allergy Clin Immunol 1980; 65: 61
   PubMed Web of Science ®Google Scholar
• Larsson S, Svedmyr N. A comparison of two models of administering beta2-adrenergic stimulants in asthmatics: Tablets and metered aerosol. Scand J Resp Dis Suppl 1977; 101: 79
   PubMedGoogle Scholar
• Conolly M E, Warrell D A, Newton Howes J H, Paterson J W, Beilin L J, Robertson D G, Dollery C T. A comparison of the cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Postgrad Med J (Suppl) 1971; 47: 77
   Web of Science ®Google Scholar
• Popa V, Werner P. Dose-related dilatation of airways after inhalation of metaproterenol sulfate. Chest 1976; 70: 205
   PubMed Web of Science ®Google Scholar
• Freedman B J, Hill G B. Comparative study of duration of action and cardiovascular effects of bronchodilator drugs. Thorax 1971; 26: 46
   PubMed Web of Science ®Google Scholar
• Sackner M A, Silva G. Effects of terbutaline aerosol in reversible airway obstruction. Chest 1978; 73: 802
   PubMed Web of Science ®Google Scholar
• Sovijarvi A R, Poybonen L, Kellowaki L, Muitari A. Effects of acute and long-term bronchodilator treatment on regional lung function in asthma, assessed with krypton-81m and technitium-99m-labelled macroaggregates. Thorax 1982; 37: 516
   PubMedGoogle Scholar
• Williams M H, Kane C. Dose response of patients with asthma to inhaled isoproternol. Am Rev Resp Dis 1975; 111: 321
   PubMedGoogle Scholar
• Choo-Kang Y FJ, Simpson W T, Grant W B. Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J 1969; 2: 287
   PubMed Web of Science ®Google Scholar
• Manicatide M A, Racoveanu C L, Nicholescu V, Teculescu D B. Comparative assessment of the efficiency of three new bronchodilators (sal-butamol, terbutaline, Th 1165a) in the management of patients with chronic obstructive lung disease. Rev Roum Med Int 1973; 10: 43
   PubMedGoogle Scholar
• Marlin G E, Turner P. The relative potencies and beta2 selectivity of intravenous rimiterol, sal-butamol, and isoprenaline by the intravenous route in man. Br J Clin Pharmacol 1975; 2: 41
   PubMed Web of Science ®Google Scholar
• Jones R M, Stockley R A, Bishop J M. Early effects of intravenous terbutaline in chronic obstructive bronchitis and pulmonary hypertension. Thorax 1982; 37: 746
   PubMed Web of Science ®Google Scholar
• Connolly M E, Warrell D A, Newton-Howes J A, Paterson J W, Beilin L J, Robertson D G, Dollery C T. A comparison of the cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Postgrad Med J (Suppl) 1971; 47: 77
   Web of Science ®Google Scholar
• Van Ac A, Benjamin C, Stern J D. A new bronchodilator hexoprenaline, in obstructive pulmonary disease. Scand J Resp Dis 1973; 54: 28
   PubMedGoogle Scholar
• Wood D W, Downes J J, Scheinkopf H. Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus. J Allergy Clin Immunol 1972; 50: 25
   Web of Science ®Google Scholar
• Fitchett D H, McNichol M W, Riordan J F. Intravenous salbutamol in the management of status asthmaticus. Br Med J 1975; 1: 53
   PubMed Web of Science ®Google Scholar
• Klaustermeyer W B, diBernardo R L, Hale F C. Intravenous isoproterenol: Rationale for bronchial asthma. J Allergy Clin Immunol 1975; 55: 325
   PubMed Web of Science ®Google Scholar
• Williams S J, Parrish R W, Seaton A. Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J 1975; 4: 685
   PubMed Web of Science ®Google Scholar
• Thiringer G, Svedmyr N. Comparison of infused and inhaled terbutaline in patients with asthma. Scand J Resp Dis Suppl 1977; 101: 95
   PubMedGoogle Scholar
• Smith P A, Henrich A E, Leffler C T, Harris M MH, Lyons H. A comparative study of sub-cutaneously administered terbutaline and epinephrine in the treatment of acute bronchial asthma. Chest 1977; 71: 129
   PubMed Web of Science ®Google Scholar
• Da Costa J L, Goth B K. A comparative trial of subcutaneous terbutaline, Th 1165a and adrenaline in bronchial asthma. Med J Austral 1973; 2: 588
   PubMed Web of Science ®Google Scholar
• Arner B. A comparative clinical trial of different subcutaneous doses of terbutaline and or-ciprenaline in brochial asthma. Acta Med Scand Supp 1970; 512: 45
   PubMedGoogle Scholar
• Holten K. Bronchodilator effect on blood gasses after subcutaneous injection and inhalation of terbutaline. J Dis Chest 1976; 68: 111
   Google Scholar
• Chervinsky P, Chervinsky G. Metaproterenol tablets: Their duration of effect by comparison with ephedrine. Current Ther Res 1975; 17: 507
   PubMed Web of Science ®Google Scholar
• Kennedy M CS, Jackson S LO. Oral sym-paromimetic amines in treatment of asthma. Br Med J 1963; 2: 1506
   PubMedGoogle Scholar
• Dulfano M J, Glass P. Evaluation of a new beta2 adrenergic receptor stimulant, terbutaline, in bronchial asthma. A comparison with ephedrine. Current Ther Res 1972; 15: 150
   Web of Science ®Google Scholar
• Tashkin D P, Meth R, Simmons D H, Lees Y E. Double-blind comparison of acute bronchial and cardiovascular effects of oral terbutaline and ephedrine. Chest 1975; 68: 133
   PubMed Web of Science ®Google Scholar
• Wilson A F, Novey H S, Cliniger D, Davis J, White D. Cardiopulmonary effects of long-term bronchodilator administration. J Allergy Clin Immunol 1976; 58: 204
   PubMed Web of Science ®Google Scholar
• Steen S N, Smith R, Kno J, Ziment I, Beal G N. Effect of fenoterol on airway conductance in asthmatic patients. IRCS Med Sci 1975; 3: 591
   Google Scholar
• Miller J, Wallace D, Grieco M H, Frenkel R, Larsen K. Double-blind trial of oral carbuterol in bronchial asthma. Ann Allergy 1977; 38: 12
   PubMedGoogle Scholar
• Chodosh S, Baigelman W, Doraiswami S. Controlled comparison of carbuterol, a new beta-adrenergic bronchodilator, with ephedrine and isoproternol. Chest 1975; 68: 406
   Web of Science ®Google Scholar
• Linehan W, Griffin J P. Oral preparations of iso-etharine compared with orciprenaline and cho-line theophyllnate. Br J Dis Chest 1971; 65: 44
   PubMedGoogle Scholar
• Sinha B N, Allen G W, Lees A W. Oral orciprenaline, salbutamol and isoetharine compared. Br J Dis Chest 1973; 67: 61
   PubMedGoogle Scholar
• O'Donnell T U, Butler G M, Tocker M D. A comparison of orciprenaline and salbutamol administered orally in 12 adult asthmatic patients. Postgrad Med J (Suppl) 1971; 47: 115
   Web of Science ®Google Scholar
• Formgren H. A clinical comparison of oral terbutaline and orciprenaline. Scand J Resp Dis 1970; 51: 203
   PubMedGoogle Scholar
• Legge J S, Gaddie J, Palmer K NV. Comparison of two oral selective beta2 adrenergic stimulant drugs in bronchial asthma. Br Med J 1971; 1: 637
   PubMed Web of Science ®Google Scholar
• Minette A. Spirometric study of the bron-chodilating effects of hydroxyphenyl orciprenaline (Th 1165a) in various forms in a group of 124 coal miners suffering from bronchospasm. Respiration 1970; 27: 276
   PubMed Web of Science ®Google Scholar
• Benjamin C, Pinder R M, Brogden R N, Speight T M, Avery G S. Hexoprenaline: A review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. Drugs 1977; 14: 1
   PubMed Web of Science ®Google Scholar
• Homes T. A comparative clinical trial of meta-proterenol and isoproterenol as bronchodilator aerosols. Clin Pharmacol Ther 1968; 9: 615
   PubMed Web of Science ®Google Scholar
• Pelz H H. Metaproterenol, a new bronchodilator: Comparison with isoproterenol. Am J Med Sci 1967; 63: 321
   Google Scholar
• Howard L A, Coleman M. A crossover comparison of isoproterenol, metaproterenol and isoetharine by spirometric determination. Ann Allergy 1967; 25: 512
   PubMedGoogle Scholar
• Sadoul P, Sentini M. A comparison of the action of salbutamol and of isoprenaline on airway resistance in 30 patients with obstructive airway disease. Postgrad Med J (Suppl) 1971; 47: 14
   Web of Science ®Google Scholar
• Warrel D A, Robertson D G, Newton-Howes J, Connolly M E, Paterson J W, Beilin L J, Dollery C T. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J 1970; 1: 65
   PubMedGoogle Scholar
• Tola E, Kellomahki L, Pylkas A. Double blind comparison of isoprenaline, orciprenaline, and salbutamol aerosols in patients with asthma. Postgrad Med J (Suppl) 1971; 47: 62
   Web of Science ®Google Scholar
• Racoveanu C, Stanescu D C, Manicatide M, Stroescu V. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study. Postgrad Med J (Suppl) 1971; 47: 83
   Web of Science ®Google Scholar
• Formgren H. Clinical comparison of inhaled ter-butaline and orciprenaline in asthmatic patients. Scand J Resp Dis 1970; 51: 203
   PubMedGoogle Scholar
• Gaddie J, Legge J S, Palmer K NV. Aerosols of salbutamol, terbutaline and isoprenaline/phe-nylepinephrine in asthma. Br J Dis Chest 1973; 67: 215
   PubMedGoogle Scholar
• Brandon M L. Long term study comparing fenoterol and isoproterenol inhalations in athmatic subjects. Ann Allergy 1978; 40: 87
   Google Scholar
• Beardshaw J, MacLean L, Chan-Yeung M. Comparison of the bronchodilatation and cardiac effects of hydroxyphenyl orciprenaline and orciprenaline. Chest 1976; 65: 507
   Web of Science ®Google Scholar
• Krieger E. Bronchial antispasmodic effect in obstructive respiratory disorders. Int J Clin Pharmacol (Suppl) 1971; 4: 102
   Google Scholar
• Groff-Lannevig J. Double-blind trial with standard doses of fenoterol and salbutamol in asthmatic children. Acta Allergo 1976; 31: 463
   PubMedGoogle Scholar
• Saleeby P R, Ziskind M M. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: Double blind comparison with isoproterenol aerosol. Current Ther Res 1975; 17: 225
   PubMed Web of Science ®Google Scholar
• Cockcroft D W, Donevan R E, Copeland G M. Car-buterol: A double-blind clinical trial comparing carbuterol and salbutamol. Current Ther Res 1976; 19: 170
   PubMed Web of Science ®Google Scholar
• Svedmyr N, Malmberg R, Thiringer G. The effect of a new adrenergic beta2 receptor stimulating agent (rimiterol R 798) in patients with chronic obstructive lung disease. Scand J Resp Dis 1972; 53: 302
   PubMedGoogle Scholar
• Bianco S, Kamburoff P L, Prime F J. Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg rimiterol (“Pulmadil”) and 0.2 mg salbutamol. Current Med Res Opin 1975; 3: 30
   PubMedGoogle Scholar
• Paterson J C, Wiley R F, Shotter M V, Grant J WB, Crompton G K. Objective and subjective comparisons of terbutaline and rimiterol bronchodilator aerosols. Br J Dis Chest 1977; 69: 267
   Google Scholar
• Schindle R. Body plethysmographysche und blutgasanalytische Untersuchungen mit Ipradol. Arzneimittel-Forschung 1970; 20: 1755
   PubMedGoogle Scholar
• Williams S J, Winner S J, Clark T JH. Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax 1981; 36: 629
   PubMed Web of Science ®Google Scholar
• Anderson P B, Goude A, Peake M D. Comparison of salbutamol given by intermittent positive-pressure breathing and pressure packed aerosol. Thorax 1982; 37: 612
   PubMed Web of Science ®Google Scholar
• Bloomfield P, Carmichael J, Petrie G R, Jewel N P, Crompton G K. Comparison of salbutamol given intravenously and by intermittent positive pressure breathing in life-threatening asthma. Br Med J 1979; 1: 848
   PubMedGoogle Scholar
• Kennedy M CS, Thursby-Pelham D C. Some adrenergic drugs and atropine methonitrate given by inhalation for asthma. A comparative study. Br Med J 1964; 2: 1018
   Google Scholar
• Chervinsky P, Herstoff R. IPPB therapy with Bronchospray or isoproternol—A comparison. J Asthma Res 1967; 4: 197
   PubMedGoogle Scholar
• Edwards G. Orciprenaline in treatment of airway obstruction in chronic bronchitis. Br Med J 1964; 2: 1015
   Google Scholar
• Swarts C L, Hyde J S. Long-term efficacy and safety of nebulized metaproterenol solution in bronchial asthma. Chest 1976; 70: 617
   PubMed Web of Science ®Google Scholar
• Choo-Kang Y FJ, Parker S S, Grant I WB. Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br Med J 1970; 4: 465
   PubMedGoogle Scholar
• Witeck F. Results of clinical studies on a novel bronchospasmolytic agent (hexoprenaline, Ipradol). Wen Klin Wochr 1971; 83: 114
   PubMedGoogle Scholar
• Milner A D, Ingram D. Bronchodilator and cardiac effects of isoprenaline, orciprenaline, and salbutamol aerosols in asthma. Arch Dis Child 1971; 46: 502
   PubMed Web of Science ®Google Scholar
• Cooke N J, Kerr A J, Willey R F, Hoare M W, Grant I WB, Crompton G K. Response to rimiterol and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br Med J 1974; 2: 250
   PubMed Web of Science ®Google Scholar
• Bennis J, Svedmyr N. A controlled comparison of salbutamol and terbutaline inhaled by IPPV in asthmatic patients: A dose-response study. Scand J Resp Dis Suppl 1977; 101: 113
   PubMedGoogle Scholar
• Blackhall M I, Cauth M, Mahoney M, O'Donnell S R. Inhalation of fenoterol (Berotec) by asthmatic children. A clinical comparison with salbutamol, orciprenaline and isoprenaline. Med J Austral 1976; 2: 439
   PubMed Web of Science ®Google Scholar
• Sackner M A, Greeneltch N, Silva G, Wanner A. Bronchodilator effects of terbutaline and epi-nephrine in obstructive lung disease. Clin Pharmacol Toxicol 1974; 16: 499
   Google Scholar
• Amory D W, Burnham S C, Cheney F W, Jr. Comparison of the cardiopulmonary effects of subcutaneously administered epinephrine and terbutaline in patients with reversible airway obstruction. Chest 1975; 67: 279
   PubMed Web of Science ®Google Scholar
• Svedmyr N, Thiringer G. The effects of salbutamol and isoprenaline on beta receptors in patients with chronic obstructive lung diseases. Postgrad Med J Suppl 1971; 47: 44
   Web of Science ®Google Scholar
• McEvoy J DS, Vall-Spinosa A, Paterson J W. Assessment of orciprenaline and isoproterenol infusions in asthmatic patients. Am Rev Resp Dis 1973; 110: 490
   Google Scholar
• Minette A. Les synmpaticomimetiques dans le traitement des affections respiratoires obstructives. Problèmes liés à l'emploi de ces substances en flacons doseurs. Rev Inst Mines 1969; 24: 1
   Google Scholar
• Larsson S, Svedmir N. A comparison of two modes of administering beta2 adrenoreceptor stimulants in asthmatics: tablets and metered aerosol. Scand J Resp Dis Suppl 1977; 101: 79
   PubMedGoogle Scholar
• Webb J, Kees J, Clark T JH. A comparison of the effects of different methods of administration of beta-i sympathomimetics in patients with asthma. Br J Dis Chest 1982; 76: 351
   PubMedGoogle Scholar
• Plit M, Goldman H I, Cassel M L. The bronchodilator action of fenoterol studied with selected pulmonary function tests. Med Proc 1972; 18: 61
   Google Scholar
• Pinder R M, Brogden R N, Speight T M, Avery G S. Hexoprenaline: A review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. Drugs 1977; 14: 1
   PubMed Web of Science ®Google Scholar
• Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta2 adrenoreceptor stimulants by different modes of administration (tablets, metered aerosol and combinations thereof). Am Rev Res Dis 1977; 116: 861
   PubMed Web of Science ®Google Scholar
• Thiringer G, Svedmyr N. Comparison of infused and inhaled terbutaline in patients with asthma. Scand J Resp Dis Suppl 1977; 101: 95
   PubMedGoogle Scholar
• Paterson J W, Shenfield G M. Bronchodilators, Part I. Tubercle (BTTA Rev Suppl 1974; 4: 25, and Part II 4:61, 1974
   Google Scholar
• Bhatia S P, Davies H J. Evaluation of tolerance after continuous and prolonged oral administration of salbutamol to asthmatic patients. Br J Clin Pharmacol 1975; 2: 463
   PubMed Web of Science ®Google Scholar
• Branscomb B V. Efficacy and side effects of fenoterol compared with isoproterenol administered by metered dose inhalers in asthma. Chest 1978; 73: 1002
   PubMed Web of Science ®Google Scholar
• Chervinsky P. The development of drug tolerance during long-term beta2-agonist bronchodilator therapy. Chest 1978; 73: 1001
   PubMed Web of Science ®Google Scholar
• Gibson J G, Tattersfield A E, Pride N B. The effects of oral salbutamol and inhaled salbutamol in asthmatic subjects. Bull Physiol Pathol Resp 1972; 8: 657
   Google Scholar
• Jenne J W, Strickland R D, Chick T W, Wall F J. Induction of beta receptor tolerance by terbutaline. J Allergy Clin Immunol 1975; 55: 96
   Web of Science ®Google Scholar
• Larsson S, Svedmyr N, Thiringer G. Lack of bronchial beta adreno-receptor tolerance in asthmatics during long term treatment with terbutaline. J Allergy Clin Immunol 1977; 59: 93
   PubMed Web of Science ®Google Scholar
• Light R W, Summer W R, Luchsinger T C. Response of patients with chronic obstructive lung disease to the regular administration of nebulized isoproterenol. Chest 1975; 67: 634
   PubMed Web of Science ®Google Scholar
• Miller W C. Long term beta2 bronchodilator therapy and the question of tolerance. Chest 1978; 73: 1000
   PubMed Web of Science ®Google Scholar
• Nelson H S, Raine D, Branch B, Kalister A. Adrenergic subsensitivity inducted by chronic administration of terbutaline and albuterol. J Allergy Clin Immunol 1976; 57: 259
   Web of Science ®Google Scholar
• Plummer A L. The development of drug tolerance to beta2 adrenergic agents. Chest 1978; 73: 949
   PubMed Web of Science ®Google Scholar
• Sims B A. Investigation of salbutamol tolerance. Br J Clin Pharmacol 1975; 1: 291
   Web of Science ®Google Scholar
• Smith R N, Davis J H. Long-term use of a salbutamol inhaler in general practice. Practitioner 1973; 210: 425
   PubMedGoogle Scholar
• Spaulding H S, Jr, Nelson H S, Branch L B. Altered cardiovascular and metabolic responses to epinephrine following the administration of epinephrine and terbutaline to normal men. J Allergy Clin Immunol 1975; 55: 97
   Web of Science ®Google Scholar
• Trautlein J, Allergria J, Gillin M. A long-term study of low dose aerosolized terbutaline sulfate. J Clin Pharmacol 1976; 16: 361
   PubMed Web of Science ®Google Scholar
• van Arsdel P, Jr, Schaffrin R M, Rosenblatt J, Sprenkle A C, Altaian L. Evaluation of oral fenoterol in chronic asthmatic patients. Chest 1978; 73: 997
   PubMed Web of Science ®Google Scholar
• Wilson A F, Novey H S, Clininger P, Davies J, White D. Pulmonary effects of long-term bronchodilator treatment. J Allergy Clin Immunol 1976; 58: 208
   Google Scholar
• Repsher L H, Miller T D, Smith S. The lack of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol. Ann Allergy 1981; 47: 405
   PubMedGoogle Scholar
• Svedmyr N, Larssen S, Thiringer G. Studies of resistance to long acting adrenergic beta stimulants in asthmatic patients. Br Med J 1976; 2: 668
   PubMedGoogle Scholar
• Harvey J E, Tattersfield A E. Airway response to salbutamol: Effects of regular salbutamol inhalations in normal, atopic and asthmatic subjects. Thorax 1982; 37: 280
   PubMed Web of Science ®Google Scholar
• Ellul-Micalef R, Fenech E F. Effect of intravenous prednisolone in asthmatics with diminished responsiveness. Lancet 1976; 2: 422
   Web of Science ®Google Scholar
• Spector S. Tolerance to beta-adrenergics and results of rising dose studies of albuterol, iso-proterenol and placebo. Ann Allergy 1981; 47: 394
   PubMedGoogle Scholar
• Holgate J T, Baldwin C J, Tattersfield A E. Beta adrenergic agonists resistance in normal human airways. Lancet 1977; 2: 375
   PubMed Web of Science ®Google Scholar
• Stephan W C, Chick T W, Avner B P, Jenne J W. Tachyphylaxis to inhaled isoproterenol and the effect of methyl-prednisolone in dogs. J Allergy Clin Immunol 1980; 65: 105
   PubMed Web of Science ®Google Scholar
• Jenne J W. The clinical pharmacology of albuterol. J Resp Dis Symp 1982; 28
   Google Scholar
• Harvey J E, Stubles W A, Wood P J, McCaughey E S, Alberti K GM, Tattersfield A E. Airway and metabolic resistance to intravenous salbutamol: A study in normal man. Clin Sci 1980; 59: 155
   Web of Science ®Google Scholar
• Trembath P W, Greenacre J K, Anderson M, Dim-Mock S, Mansfield L, Wadsworth J, Green M. Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics. J Allergy Clin Immunol 1979; 63: 395
   PubMed Web of Science ®Google Scholar
• Falliers C J. Albuterol aerosol compared with other inhaled bronchodilators. J Resp Dis Symp 1982; 38
   Google Scholar
• Keighley J F. Iatrogenic asthma associated with adrenergic aerosols. Ann Intern Med 1966; 65: 985
   PubMed Web of Science ®Google Scholar
• Reisman R E, Friedman I, Arbesman C E. Severe status asthmaticus: Prolonged treatment with assisted ventilation. J Allergy 1968; 41: 37
   Google Scholar
• Stanescu D C, van de Woestinje K P. Asthmatic attack induced by isoprenaline aerosols. Respiration 1972; 29: 532
   PubMed Web of Science ®Google Scholar
• Jenne J W, Chick T W. “Unresponsiveness” to isoproterenol. Chest 1976; 70: 691
   PubMed Web of Science ®Google Scholar
• Bouhuys A, van de Woestijne K P. Mechanical consequences of airway smooth muscle relaxation. J Appl Physiol 1971; 30: 670
   PubMed Web of Science ®Google Scholar
• Misra N P, Tivari U C, Khemchandani G T. Double-blind crossover study of carbuterol and salbutamol in bronchial asthma. J Int Med Res 1981; 9: 261
   PubMed Web of Science ®Google Scholar
• Ng K H, Sen D K. Hypotension with intravenous salbutamol in premature labor. Br Med J 1976; 3: 257
   Google Scholar
• Helander S, Lindell S E, Lindholm B, Solderholm B, Westling B. The haemodynamic and respiratory effects of adrenaline and theophylline derivatives in bronchial asthma. Scand J Resp Dis 1967; 68: 45
   Google Scholar
• Tai E, Read J. Response of blood gas tensions to aminophylline and isoprenaline in patients with asthma. Thorax 1967; 22: 543
   PubMed Web of Science ®Google Scholar
• Palmer K NV, Flenley D C. Pathophysiology of gas exchange and arterial blood gas and pH in asthma. Bronchial Asthma, E B Weiss, M S Segal. Little Brown and Co, Boston 1977; 317
   Google Scholar
• Knudson R J, Constantine H P. An effect of isoproterenol on ventilation perfusion in asthmatic versus normal subjects. J Appl Physiol 1966; 22: 402
   Web of Science ®Google Scholar
• Ingram R J, Jr, Krumpe P E, Duffel G M, Maniscalco B. Ventilation perfusion changes after aerosolized isoproterenol in asthma. Am Rev Resp Dis 1970; 101: 364
   PubMedGoogle Scholar
• Palmer K NV, Diament M L. Effect of salbutamol on spriometry and blood gas tension in bronchial asthma. Br Med J 1969; 1: 31
   PubMedGoogle Scholar
• Heel R C, Brogden R N, Speight T M, Avery G S. Fenoterol: A review of its pharmacological properties and therapeutic efficacy in asthma. Drugs 1978; 15: 3
   PubMed Web of Science ®Google Scholar
• Harris L H. Effects of isoprenaline plus phenyl-ephrine by pressurized aerosol on blood gases, ventilation and perfusion in chronic obstructive lung disease. Br Med J 1970; 2: 576
   Google Scholar
• Palmer K NV, Legge J S, Hamilton W FD, Diament M L. Effect of a selective beta adrenergic blocker in preventing falls in arterial oxygen tension following isoprenaline in asthmatic subjects. Lancet 1969; 2: 1092
   PubMed Web of Science ®Google Scholar
• Carlstrom S, Westling H. Metabolic, circulatory and respiratory effects of a new sympathomime-tic beta-receptor-stimulating agent, terbutaline, compared with those orciprenaline. Acta Med Scand Suppl 1970; 512: 33
   PubMedGoogle Scholar
• Rossing T H, Fanta C H, Goldstein D H, Snapper J S, McFadden E R, Jr. Emergency therapy of asthma: comparison of the acute effects of par-enteral and inhaled sympathomimetics and infused aminophylline. Am Rev Resp Dis 1980; 122: 365
   PubMed Web of Science ®Google Scholar
• Pierce R J, Payne C R, Williams S J, Denison D M, Clark T JH. Comparison of intravenous and inhaled terbutaline in the treatment of asthma. Chest 1981; 79: 506
   PubMed Web of Science ®Google Scholar
• Josephson G W, MacKenzie E J, Lietman P S, Gibson G. Emergency treatment of asthma. A comparison of two treatment regimens. J Am Med Assoc 1979; 242: 639
   PubMed Web of Science ®Google Scholar
• Arner B. A comparative clinical trial of different subcutaneous doses of terbutaline and orciprenaline in bronchial asthma. Acta Med Scand Suppl 1970; 112: 45
   Google Scholar
• Sackner M A, Greenveltch H, Silva G, Wanner A. Bronchodilator effect of terbutaline and epi-nephrine in obstructive lung disease. Clin Pharmacol Ther 1974; 16: 499
   PubMed Web of Science ®Google Scholar
• Lyons H A. Bronchodilator Adrenergic Therapy in Bronchial Asthma, E B Weiss, M S Segal. Little Brown and Co, Boston 1976
   Google Scholar
• Lowell F C. Therapeutic Schedules in Asthma in Bronchial Asthma, E B Weiss, M S Segal. Little Brown and Co, Boston 1976
   Google Scholar
• Falliers C J. Isoproterenol aerosols for childhood asthma: Estimation of need and efficacy with computerized clinical and laboratory data. J Resp Dis Symp 1982; 13
   Google Scholar
• Anderson S F, Rozea P J, Dolton R, Lindsay D A. Inhaled and oral bronchodilator therapy in exercise-induced asthma. Austral NZ J Med 1975; 5: 544
   PubMedGoogle Scholar
• Clark R A, Anderson P B. Combined therapy with salbutamol and beclomethasone inhalers in chronic asthma. Lancet 1978; 2: 70
   PubMed Web of Science ®Google Scholar
• Billing B, Dahlqvist R, Aile M G, Hornblad Y, Ripp E. Separate and combined use of terbutaline and theophylline in asthma. Eur J Resp Dis 1982; 63: 399
   PubMedGoogle Scholar